ÂÜÀòÂÒÂ×

David is a veteran of the pharmaceutical industry during which he has spent the majority of his career working in the rare and ultra-rare disease marketplace. He has helped launch seven first-to-market, first-in-therapy rare and ultra-rare disease products, and eight biotech commercial startups. David has worked with some of the best-known names in pharmaceuticals, including Schering-Plough, Rhone Poulenc Rorer, Merck, Guilford, Pharmion, Viropharma, Shire Human Genetics, Aegerian, MTPA, and Novartis. David earned his BS in Business Marketing from Florida State University.